Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation

Since cisplatin achieved clinical success, transition metal platinum (Pt) drugs have been effectively used for the treatment of cancer. Iridium (Ir) compounds are considered to be potential alternatives to Pt compounds, as they possess promising anticancer effects with minor side effects. Platelet a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Mol Med
Main Authors: Shyu, Kou-Gi, Velusamy, Marappan, Hsia, Chih-Wei, Yang, Chih-Hao, Hsia, Chih-Hsuan, Chou, Duen-suey, Jayakumar, Thanasekaran, Sheu, Joen-Rong, Li, Jiun-Yi
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2018
Teme:
Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5846649/
https://ncbi.nlm.nih.gov/pubmed/29436605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3472
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki